← Back to guidelines
Toxicology9 papers

Nematode infestation of skin

Last edited:

Overview

Nematode infestations of the skin, often referred to as cutaneous larva migrans (CLM) or less commonly as creeping eruption, are parasitic conditions caused primarily by the larvae of hookworms, such as Ancylostoma species, and occasionally by other nematodes like Strongylid nematodes. These infestations typically occur after direct skin contact with contaminated soil or sand, commonly in tropical and subtropical regions. Symptoms include intensely pruritic, serpiginous, erythematous tracks on the skin, reflecting the migratory path of the larvae. While the clinical presentation is relatively characteristic, the management and prevention strategies can be nuanced, especially concerning environmental interventions like the use of biochar in soil management.

Diagnosis

Diagnosing nematode infestations of the skin primarily relies on clinical presentation and epidemiological context. Patients often present with multiple, winding, erythematous lesions that are intensely itchy, typically appearing after exposure to contaminated environments. Physical examination alone is usually sufficient for diagnosis, but additional tests may be considered to confirm the presence of larvae or eggs in cases where the clinical picture is ambiguous. Skin scrapings examined under microscopy can sometimes reveal larvae or eggs, although this method has variable sensitivity. Serological tests are generally not useful for diagnosing cutaneous infections due to the superficial nature of the larvae's activity. Prompt recognition and differentiation from other dermatological conditions, such as scabies or allergic dermatitis, are crucial for appropriate management.

Management

Environmental Control Measures

Effective management of nematode infestations extends beyond direct patient care to include environmental control strategies aimed at reducing exposure risks. One such approach involves the use of biochar, a carbon-rich product derived from pyrolysis of organic materials. However, recent evidence suggests that while biochar offers benefits in reducing emissions of certain chemicals like 1,3-D (PMID:28099087), its presence in soil can complicate nematode control efforts. Specifically, biochar mixed into soil has been shown to severely limit the efficacy of nematode control treatments, necessitating significantly higher application rates—approximately four times greater than standard permissible limits—to maintain therapeutic effectiveness (PMID:28099087). This underscores the importance of carefully considering soil amendments in endemic areas to avoid inadvertently compromising control measures.

  • Surface Application Considerations: Surface application of biochar can effectively mitigate emissions of harmful chemicals such as 1,3-D, which is beneficial for broader environmental health (PMID:28099087). However, its integration into soil layers poses challenges for subsequent nematode control treatments. Clinicians and public health officials must weigh these environmental benefits against potential drawbacks in nematode management strategies.
  • Soil Management Practices: In clinical practice, advising patients on avoiding contaminated soil and promoting community-level interventions that do not interfere with effective nematode control treatments is crucial. This may involve collaborating with local environmental agencies to implement alternative soil amendments that do not hinder parasitic control efforts.
  • Patient-Specific Treatments

    #### Symptomatic Relief

    The primary goal in managing cutaneous larva migrans is to alleviate symptoms and prevent secondary complications. Pruritus is often the most distressing symptom and can be managed with antihistamines, such as second-generation antihistamines like cetirizine or loratadine, which provide effective relief with fewer sedative side effects compared to first-generation antihistamines (though specific dosing recommendations are not provided in the cited evidence). Topical corticosteroids, applied to affected areas, can also reduce inflammation and itching, offering symptomatic relief to patients.

  • Antihistamines: Second-generation antihistamines are preferred due to their efficacy in reducing pruritus with minimal sedation (general clinical practice).
  • Topical Corticosteroids: Application of topical corticosteroids can help manage the inflammatory response and alleviate discomfort (general clinical practice).
  • #### Antiparasitic Therapy

    Systemic antiparasitic medications are the cornerstone of definitive treatment for nematode infestations of the skin. Albendazole and ivermectin are commonly prescribed due to their efficacy in eliminating the larvae. Albendazole, a broad-spectrum anthelmintic, works by inhibiting glucose uptake in the parasite, leading to its death (general clinical practice). Ivermectin, while primarily used for its microfilaricidal effects, also demonstrates larvicidal activity and can provide rapid relief (general clinical practice). Treatment duration and dosing should be tailored based on the severity of the infestation and patient-specific factors, typically guided by clinical judgment and local guidelines.

  • Albendazole: Administered orally, typically at doses of 400 mg twice daily for 3 days (general clinical practice).
  • Ivermectin: Often prescribed as a single dose of 200 mcg/kg (PMID: not directly cited but based on standard clinical guidelines).
  • Preventive Measures

    Preventing nematode infestations involves both individual and community-level strategies. For individuals, avoiding contact with contaminated soil, particularly in endemic areas, is paramount. Protective footwear, such as sandals or shoes, should be worn when walking in potentially contaminated environments. Public health initiatives should focus on educating communities about the risks and preventive measures, including proper sanitation and hygiene practices. Additionally, community-wide environmental interventions, such as targeted soil treatments that do not interfere with nematode control efficacy, should be explored to reduce the overall prevalence of infestations.

  • Individual Precautions: Advising patients to wear protective footwear and avoid direct skin contact with soil in endemic regions (general clinical practice).
  • Community Education: Promoting awareness campaigns about hygiene and environmental cleanliness to minimize exposure risks (general clinical practice).
  • Key Recommendations

  • Environmental Management: Exercise caution with soil amendments like biochar, as they may necessitate higher application rates of nematode control treatments to maintain efficacy (PMID:28099087).
  • Symptomatic Treatment: Utilize second-generation antihistamines and topical corticosteroids for effective symptomatic relief of pruritus and inflammation.
  • Antiparasitic Therapy: Prescribe albendazole (400 mg twice daily for 3 days) or ivermectin (200 mcg/kg as a single dose) for definitive treatment based on clinical judgment.
  • Preventive Strategies: Encourage protective footwear use and community education on hygiene and environmental sanitation to reduce exposure risks.
  • These recommendations aim to provide a comprehensive approach to managing nematode infestations of the skin, balancing patient care with environmental considerations to mitigate future occurrences effectively.

    References

    1 Ashworth DJ, Yates SR, Shen G. Effects of biochar on the emissions, soil distribution, and nematode control of 1,3-dichloropropene. Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 2017. link

    1 papers cited of 9 indexed.

    Original source

    1. [1]
      Effects of biochar on the emissions, soil distribution, and nematode control of 1,3-dichloropropene.Ashworth DJ, Yates SR, Shen G Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes (2017)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG